NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
24/02/2026
Voltar para busca
Dado oficial do USPTO
CRISPR THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
25/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
41, 42
Data de depósito
11/04/2018
Data de registro
19/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/02/2026
Última transação
25/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Supplemental Register
Primeiro uso
2013-11-00
Primeiro uso no comércio
2013-11-00
Código do desenho
3
Tipo de titular
99
Localização do titular
ZUG V8, CH
Examinador
SCHIMPF, TIMOTHY O
Localização atual
Historical data usage
Descrição da marca
The mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR", with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS".
Titulares e representantes
Titulares
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Representantes
Tiffany D. Gehrke Marshall Gerstein & Borun LLP
Classificação técnica
Classes Nice
Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Education servicesproviding online non-downloadable articles and newsletters in the fields of pharmaceuticalsgeneticsgenome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy
Classe 42
Scientific research and developmentgene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceuticalmedicalscientificbiopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticalsgeneticsgenome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticalsgeneticsgenome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
24/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/02/2026
ES8R
TEAS SECTION 8 RECEIVED
03/10/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19/11/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/04/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/08/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/08/2020
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
19/11/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/10/2019
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/10/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
25/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
25/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/04/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
21/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/03/2019
GNRT
NON-FINAL ACTION E-MAILED
13/03/2019
CNRT
NON-FINAL ACTION WRITTEN
13/03/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
21/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/02/2019
ALIE
ASSIGNED TO LIE
12/02/2019
DRRR
DIVISIONAL REQUEST RECEIVED
07/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/02/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/08/2018
GNRT
NON-FINAL ACTION E-MAILED
07/08/2018
CNRT
NON-FINAL ACTION WRITTEN
07/08/2018
DOCK
ASSIGNED TO EXAMINER
31/07/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
20/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/04/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CRISPR THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.